192 related articles for article (PubMed ID: 19917958)
21. Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family.
Ali MZ; Blatterer J; Khan MA; Schaflinger E; Petek E; Ahmad S; Khan E; Windpassinger C
Mol Genet Genomic Med; 2020 Feb; 8(2):e1060. PubMed ID: 31923348
[TBL] [Abstract][Full Text] [Related]
22. CXCL1 Inhibition Regulates UVB-Induced Skin Inflammation and Tumorigenesis in Xpa-Deficient Mice.
Kunisada M; Hosaka C; Takemori C; Nakano E; Nishigori C
J Invest Dermatol; 2017 Sep; 137(9):1975-1983. PubMed ID: 28528167
[TBL] [Abstract][Full Text] [Related]
23. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
24. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
[TBL] [Abstract][Full Text] [Related]
25. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
26. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
[TBL] [Abstract][Full Text] [Related]
27. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
28. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
29. Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.
Ramkumar HL; Brooks BP; Cao X; Tamura D; Digiovanna JJ; Kraemer KH; Chan CC
Surv Ophthalmol; 2011; 56(4):348-61. PubMed ID: 21684361
[TBL] [Abstract][Full Text] [Related]
30. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma pigmentosum.
Lehmann AR; McGibbon D; Stefanini M
Orphanet J Rare Dis; 2011 Nov; 6():70. PubMed ID: 22044607
[TBL] [Abstract][Full Text] [Related]
32. Neurological symptoms and natural course of xeroderma pigmentosum.
Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
[TBL] [Abstract][Full Text] [Related]
33. [Xeroderma pigmentosum: children of the moon].
Herouy Y; Krutmann J; Norgauer J; Schöpf E
J Dtsch Dermatol Ges; 2003 Mar; 1(3):191-8. PubMed ID: 16285494
[TBL] [Abstract][Full Text] [Related]
34. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
36. Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation.
Musich PR; Li Z; Zou Y
Adv Exp Med Biol; 2017; 996():41-54. PubMed ID: 29124689
[TBL] [Abstract][Full Text] [Related]
37. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
[TBL] [Abstract][Full Text] [Related]
38. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
[TBL] [Abstract][Full Text] [Related]
39. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities.
Sato K; Watatani M; Ikenaga M; Kozuka T; Kitano Y; Yoshikawa K; Mimaki T; Abe J; Sugita T
Br J Dermatol; 1987 Jan; 116(1):101-8. PubMed ID: 3814505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
